Literature DB >> 10407969

The role of objective personality inventories in suicide risk assessment: an evaluation and proposal.

W B Johnson1, R Lall, B Bongar, M D Nordlund.   

Abstract

Objective personality assessment instruments offer a comparatively underutilized source of clinical data in attempts to evaluate and predict risk for suicide. In contrast to focal suicide risk measures, global personality inventories may be useful in identification of long-standing styles that predispose persons to eventual suicidal behavior. This article reviews the empirical literature regarding the efficacy of established personality inventories in predicting suicidality. The authors offer several recommendations for future research with these measures and conclude that such objective personality instruments offer only marginal utility as sources of clinical information in comprehensive suicide risk evaluations. Personality inventories may offer greatest utility in long-term assessment of suicide risk.

Entities:  

Mesh:

Year:  1999        PMID: 10407969

Source DB:  PubMed          Journal:  Suicide Life Threat Behav        ISSN: 0363-0234


  4 in total

1.  The clinical utility of the MMPI-2-RF Suicidal/Death Ideation Scale.

Authors:  Emily Gottfried; Lindsay Bodell; Joyce Carbonell; Thomas Joiner
Journal:  Psychol Assess       Date:  2014-07-28

2.  Understanding suicide in Australian farmers.

Authors:  Fiona Judd; Henry Jackson; Caitlin Fraser; Greg Murray; Garry Robins; Angela Komiti
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-01-01       Impact factor: 4.328

3.  Personality factors and suicide risk in a representative sample of the German general population.

Authors:  Victor Blüml; Nestor D Kapusta; Stephan Doering; Elmar Brähler; Birgit Wagner; Anette Kersting
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

4.  Prevalence and factors associated with suicidal ideation among farmers.

Authors:  Emelynne Gabrielly de Oliveira Santos; Kelly Graziani Giacchero Vedana; Isabelle Ribeiro Barbosa
Journal:  PLoS One       Date:  2022-09-06       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.